-
Distinct Plasma Proteomic Signatures Distinguish MASLD From Non-Steatotic Individuals but Not From MetALD. Liver Int. 2026 Oct; 46(10):e70873.
Jakhar N, Seibel T, Mironova M, Meeßen C, Clusmann J, Chen Y, Raju TB, Koop PH, Pearce JE, Costa IG, Stiehl T, Schuppert A, Schneider KM, Rotman Y, Schneider CV. PMID: 42809338; PMCID: PMC13623009.
View in:
PubMed Mentions:
-
International expert panel review for the use of resmetirom and semaglutide in the management of MASH-related fibrosis: clinical practice update. Gut. 2026 Sep 11.
Mironova M, Ratziu V, Rinella ME, Bansal MB, Noureddin M, Alkhouri N, Anstee QM, Newsome PN, Schattenberg JM, Sanyal AJ, Loomba R. PMID: 42728029.
View in:
PubMed Mentions:
-
Editorial: Clinically Meaningful Cut-Points for ELF in Fibrosis Risk Stratification in MASLD. Aliment Pharmacol Ther. 2026 Aug 24.
Mironova M, Loomba R. PMID: 42638176.
View in:
PubMed Mentions:
-
Clinical Trial: Phase 3 Trial of Resmetirom Versus Placebo in Metabolic Dysfunction-Associated Steatohepatitis-Reanalysis of Fibrosis Stage 2-3 Subset. Aliment Pharmacol Ther. 2026 Oct; 64(7):919-929.
Mironova M, Padmanabhan K, Schneider D, Schattenberg JM, Loomba R. PMID: 42527732; PMCID: PMC13559488.
View in:
PubMed Mentions: Fields:
-
Genotypes of Hepatitis B and D Viruses Among Patients With Hepatitis D in the United States. J Viral Hepat. 2026 Jul; 33(7):e70186.
Lopez A, Gopalakrishna H, Chang S, Manhas S, Peinovich N, Richards C, Chee G, Martin R, Mateo R, Mironova M, Swanson BE, Meyer WA, Marlowe EM, Li C, Mo H, Heller T, Maiorova E, Koh C. PMID: 42237932.
View in:
PubMed Mentions: Fields:
Translation:
HumansCells
-
Prevalence and Risk Factors Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease and Advanced Fibrosis Among Overweight Individuals: Implications for Screening Guidelines. Am J Gastroenterol. 2026 Jun 24.
Mironova M, Tesfai K, Madamba E, Richards L, Bettencourt R, Docherty M, Loomba R. PMID: 42333597.
View in:
PubMed Mentions: Fields:
-
Clinical Use of Noninvasive Testing for Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease. Clin Gastroenterol Hepatol. 2026 Sep; 24(9):2370-2373.
Mironova M, Loomba R. PMID: 42026017.
View in:
PubMed Mentions: Fields:
-
Serum Proteomics of Insulin Resistance Disorders Distinguish MASLD From Lipodystrophy and Insulin Receptor Defects. J Clin Endocrinol Metab. 2026 Mar 17; 111(4):1057-1065.
Mironova M, Wing A, Abel BS, Podszun MC, Brown RJ, Rotman Y. PMID: 41058075; PMCID: PMC13017331.
View in:
PubMed Mentions:
1 Fields:
Translation:
HumansCells
-
Exceptionally Long Recurrence-Free Survival in a Male Patient With Fibrolamellar Hepatocellular Carcinoma. Case Reports Hepatol. 2026; 2026:7445319.
Townsend EC, Sharma D, Gopalakrishna H, Mironova M, Kleiner DE, Heller T. PMID: 41669374; PMCID: PMC12883663.
View in:
PubMed Mentions:
-
Noninvasive Markers Associated With Portal Hypertension and Varices in Patients With Noncirrhotic Portal Hypertension. Clin Transl Gastroenterol. 2026 Feb 01; 17(2):e00956.
Gopalakrishna H, Mironova M, Majeed NA, Scott S, Norman-Wheeler J, Koh C, Heller T. PMID: 41410017; PMCID: PMC12922926.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Real World Performance of the Model for End-Stage Liver Disease Score Across Different Races and Ethnicities. Dig Dis Sci. 2026 Feb; 71(2):643-650.
Mironova M, Zaiman Z, Samuel MC, Gichoya JW, Holder AL, Celi LA, Stein DJ. PMID: 40900363.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Cardiopulmonary changes and its association with clinical features in noncirrhotic portal hypertension. World J Gastroenterol. 2025 Aug 14; 31(30):109256.
Gopalakrishna H, Nguyen ML, Mironova M, Viana Rodriguez GM, Afruza R, Chakraborty M, Menkart MG, Oringher JL, Scott S, Nair GB, Kleiner DE, Koh C, Fallon M, Sachdev V, Heller T. PMID: 40904883; PMCID: PMC12404138.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Asymptomatic Massive Choledocholithiasis in a Patient With Sickle Cell Disease and History of Remote Cholecystectomy. Am J Gastroenterol. 2025 Dec 01; 120(12):2753.
Hwang SY, Mironova M, Grecco ML, Heller T. PMID: 40304400.
View in:
PubMed Mentions: Fields:
-
Immigration Factors and Monitoring of Chronic Hepatitis B Infection Among Foreign-Born: The FOCUS-HBV Multicentre Cohort. Aliment Pharmacol Ther. 2025 Jun; 61(12):1913-1922.
Zhou K, Lee A, Wong C, Rangnekar AS, Chen A, Ajokubi J, Keller AI, Smith CI, Hitawala AA, Mironova M, Gopalakrishna H, Norman-Wheeler J, Ghany MG, Dodge JL, Terrault NA, Hsu CC. PMID: 40202373; PMCID: PMC12970947.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Portal sinusoidal vascular diseases: Assessment and therapy. Hepatology. 2025 Apr 04.
Mironova M, Gopalakrishna H, Koh C, Kleiner DE, Heller T. PMID: 40194304.
View in:
PubMed Mentions:
2 Fields:
-
Letter: Prospective evaluation of patients with non-cirrhotic portal hypertension-A single centre study. Authors' reply. Aliment Pharmacol Ther. 2024 Nov; 60(10):1489-1490.
Mironova M, Gopalakrishna H, Heller T. PMID: 39329439.
View in:
PubMed Mentions:
1 Fields:
-
Porto-Sinusoidal Vascular Disease in Congenital Erythropoietic Porphyria Needing Liver Transplantation. ACG Case Rep J. 2024 May; 11(5):e01336.
Gopalakrishna H, Mironova M, Malik S, Faust A, Khurram N, Koh C, Kleiner DE, Heller T. PMID: 38682079; PMCID: PMC11049708.
View in:
PubMed Mentions:
1
-
Hepatitis B Vaccine: Four Decades on. Vaccines (Basel). 2024 Apr 18; 12(4).
Mironova M, Ghany MG. PMID: 38675820; PMCID: PMC11053833.
View in:
PubMed Mentions:
11
-
Prospective evaluation of patients with non-cirrhotic portal hypertension: A single centre study. Aliment Pharmacol Ther. 2024 06; 59(12):1527-1538.
Mironova M, Gopalakrishna H, Viana Rodriguez GM, Abdul Majeed N, Hitawala AA, Fuss IJ, Bergerson JRE, Faust AJ, Laurin JM, Norman-Wheeler J, Scott S, Hercun J, Redd B, Kleiner DE, Koh C, Heller T. PMID: 38629442.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Granulomatous liver diseases. Hepatol Commun. 2024 04 01; 8(4).
Mironova M, Gopalakrishna H, Rodriguez Franco G, Holland SM, Koh C, Kleiner DE, Heller T. PMID: 38497932; PMCID: PMC10948139.
View in:
PubMed Mentions:
10 Fields:
Translation:
Humans
-
Meta-analysis: Incidence of cirrhosis and hepatocellular carcinoma in patients with Fontan palliation. Aliment Pharmacol Ther. 2024 May; 59(9):1020-1032.
Hitawala AA, Gopalakrishna H, Mironova M, Livinski AA, Wright EC, Downing T, Ito S, Fisher SD, Cedars AM, John AS, Heller T. PMID: 38497159.
View in:
PubMed Mentions:
3 Fields:
Translation:
Humans
-
Chronic Liver Disease in Patients with Prolidase Deficiency: A Case Series. Case Rep Gastroenterol. 2024 Jan-Dec; 18(1):49-57.
Gopalakrishna H, Asif B, Rai A, Conjeevaram HS, Mironova M, Kleiner DE, Freeman AF, Heller T. PMID: 38304571; PMCID: PMC10834036.
View in:
PubMed Mentions:
3
-
Advances and Challenges in Managing Hepatitis D Virus: Evolving Strategies. Curr Hepatol Rep. 2024; 23(1):32-44.
Gopalakrishna H, Mironova M, Dahari H, Koh C, Heller T. PMID: 38533303; PMCID: PMC10965034.
View in:
PubMed Mentions:
6
-
Risk of Hepatocellular Carcinoma After Spontaneous Clearance of Hepatitis C Virus and in Noncirrhosis Chronic Hepatitis C Patients With Sustained Virological Response: A Systematic Review. Clin Infect Dis. 2023 08 14; 77(Suppl 3):S245-S256.
Hsu CC, Gopalakrishna H, Mironova M, Lee MH, Chen CJ, Yang HI, Wiese M, Chang KM, Wright EC, Abijo T, Feld JJ, Kaplan DE. PMID: 37579210; PMCID: PMC10425144.
View in:
PubMed Mentions:
3 Fields:
Translation:
HumansCells
-
Fecal microbiota transplantation may reduce the mortality of patients with severe and fulminant Clostridioides difficile infection compared to standard-of-care antibiotics in a community hospital. J Dig Dis. 2022 Aug; 23(8-9):500-505.
Mironova M, Ehrlich AC, Grinspan A, Protano MA. PMID: 36183340.
View in:
PubMed Mentions:
2 Fields:
Translation:
HumansCells